Dark Forest Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Dark Forest Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,082	Closed	-$739K	–	1201
2025 Q3	$739K	Sell	10,082 -6,394	-39%	-$406K	0.03%	822
2025 Q2	$838K	Sell	16,476 -9,017	-35%	-$401K	0.03%	791
2025 Q1	$1.15M	Buy	25,493 +18,033	+242%	+$850K	0.05%	618
2024 Q4	$308K	Buy	+7,460	New	+$311K	0.05%	654
2024 Q2	–	Sell	-10,764	Closed	-$270K	–	810
2024 Q1	$270K	Buy	+10,764	New	+$296K	0.05%	504

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dark Forest Capital Management's MIRM Position: Q4 2025 in Review

Dark Forest Capital Management sold out of Mirum Pharmaceuticals (MIRM) in Q4 2025, closing a stake of 10,082 shares — an estimated $739K sold.

Dark Forest Capital Management first reported a position in MIRM in Q1 2024 and held it in 5 quarters. The position peaked at $1.15M in Q1 2025. 281 funds tracked by Wall St. Rank hold MIRM as of Q4 2025.

Dark Forest Capital Management reported no remaining Mirum Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Dark Forest Capital Management sold 10,082 Mirum Pharmaceuticals shares in Q4 2025, an estimated $739K.
Dark Forest Capital Management first reported a position in Mirum Pharmaceuticals in Q1 2024 and held it in 5 quarters.
Dark Forest Capital Management's Mirum Pharmaceuticals position peaked at $1.15M in Q1 2025.
281 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2025.

Based on Dark Forest Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.